Abstract An 11-mo-old infant received 12.5 times the maximum therapeutic dose of amlodipine as a result of a medication error in lieu of amoxicillin. He presented with vomiting, lethargy, breathlessness, muffled heart sounds and progressed to hypotensive shock within three hours of admission. He received mechanical ventilation, fluid therapy with normal saline and inotropes. But his parameters improved rapidly only after initiating him on insulin and dextrose infusion therapy (for 15 h) along with glucagon and calcium gluconate infusion (for 72 h). Calcium channel blockers (CCB) cause impaired insulin secretion causing hyperglycemia. High levels of blood sugar are of prognostic value rather than hemodynamic variables in CCB poisoning. A continuous infusion of 0.5 to 1 unit per kg body weight per hour of insulin along with supportive therapy including peritoneal dialysis (for deranged renal function) was used with success in managing amlodipine poisoning.
Introduction
Infants contribute about 5.25 % of poisoning exposures in humans [1] . Only one case of Amlodipine poisoning is reported in infants and this child succumbed [2] . The authors report an 11-mo-old infant with nearly fatal Amlodipine poisoning.
Case Report
A 11-mo-old infant received 6 doses of 15 mg of Amlodipine which was dispensed against prescribed Amoxicillin for lower respiratory tract infection. He presented with vomiting and reduced activity. He worsened over few hours with increasing lethargy, respiratory distress, and progressive loss of consciousness, non palpable central pulses, muffled heart sounds, bilateral crepitations over chest and hepatomegaly. His blood sugar was 382 mg/dl. Laboratory investigations including Arterial Blood Gas analysis are shown in Table 1 . On admission he had anemia, normal S Creatinine and metabolic acidosis. He received mechanical ventilation. Normal saline bolus and intravenous calcium gluconate was given. He received dopamine and adrenaline. Blood pressure remained at 70/40 mm of Hg. High dose insulin infusion at 0.5 u/kg/h with intravenous 25 % dextrose and intramuscular glucagon for maintaining euglycemia was given after initiation of vasopressors. Continuous infusion of calcium gluconate at the dose of 0.5 mEq/kg/h was started simultaneously. Blood pressure and peripheral pulses normalized after the insulin, glucose and calcium infusions. To manage renal failure, oliguria, congestive cardiac failure and pulmonary edema, peritoneal dialysis was initiated at 24 h of admission and continued for 48 h. Child improved, hence insulin infusion was tapered and stopped after 15 h. He required 48 h of mechanical ventilation. Calcium gluconate infusion was stopped after 72 h. Inotropic support was tapered over 48 h and the patient was discharged after 10 d. Liver enzymes increased after 72 h of ingestion without development of jaundice and there was no derangement of bleeding profile.
Discussion
This infant partially improved with initial management of intravenous bolus of calcium gluconate and intravenous infusion of catecholamines. After adding insulin and calcium gluconate infusion and intramuscular glucagon, vital parameters normalized rapidly. The infant improved with combined management of calcium salts, hyperinsulinemia/ euglycemia therapy, inotropes, glucagon and peritoneal dialysis. Hemodialysis is not useful in Amlodipine toxicity and role of peritoneal dialysis in Amlodipine is not clear, yet the authors performed peritoneal dialysis consequent to worsening renal function [3] . Clinical presentation of CCB overdose (hypotension, dysrhythmia, and hyperglycemia) in children may occur with doses as low as 2.5 mg and these symptoms are dose dependent, especially when the ingested dose is 10 mg or more [4] .
CCB acts by binding to α unit of the L type calcium channels. Insulin secretion being calcium dependent, blockage of the L type channel results in impaired insulin secretion causing hyperglycemia. CCB poisoning also results in insulin resistance [5] . Hyperglycemia is an important feature with prognostic value. A continuous increase in blood sugar levels may be a harbinger of sudden decline in hemodynamic variables rather than measurements of blood pressure and pulse [6] .
CCB are a potential source of risk for children due to the high dosage form strength in relation to body weight. A single dose of 10 mg Nifedipine tablet was associated with the death of an infant [7] . Amlodipine has large volume of distribution and 35-45 h of long elimination half life and overdose produces prolonged CCB toxicity [8] . The maximum therapeutic dose of Amlodipine is 0.6 mg/kg per day. This 6 kg infant received 15 mg of Amlodipine three times a day for two days (about 12.5 times the maximum dose of Amlodipine).
Management of CCB overdose includes attempts to increase transmembrane calcium flow by increasing extracellular calcium concentration (calcium salts) or by increasing intracellular cAMP concentration by adenylate cyclase stimulation (with epinephrine or glucagon) or by phosphodiesterase inhibition (with milrinone or amrinone). But these therapies have not been shown to reverse CCB cardiovascular toxicity [9] .
In aerobic conditions free fatty acids are the main energy substrate of myocardial cells. In compromised hemodynamic conditions such as CCB toxicity, these cells move to glucose utilization as the main energy substrate. But the cardiovascular compromise decreases the glucose delivery to the tissues. Understanding these mechanisms have led to the hypothesis that high dose insulin therapy can be used with great benefit in management of CCB toxicity [6] . Animal studies have shown insulin improves myocardial function during shock induced by CCB toxicity [10] .
Clinical experience with this novel therapy in children is limited and ideal dosing is not established. A continuous infusion of 0.5 to 1 unit/kg/h of insulin is often used. Hyperinsulinemia/euglycemia therapy can be recommended as first-line treatment in CCB poisonings, but further research to improve management is needed.
Conclusions
Hyperinsulinemia/euglycemia therapy is beneficial in patients with CCB induced hypotension, hyperglycemia, and acidosis. High dose insulin therapy and other standard therapies are beneficially used in combination. Avoiding medication error using various established methodologies is required to improve patient safety.
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